Whole genome sequencing data of high-grade serous ovarian cancer samples (set 8a)
Whole genome sequencing data of 26 high-grade serous carcinoma (HGSC) patients (87 samples) sequenced with MGISEQ-2000 and HiSeq X Ten.
- 84 samples
- DAC: EGAC00001001760
- Technologies: HiSeq X Ten, unspecified
DUO:0000007 version: 2019-01-07
disease specific research
This data use permission indicates that use is allowed provided it is related to the specified disease.
ModifiersMONDO:0004992
DUO:0000026 version: 2019-01-07
user specific restriction
This data use modifier indicates that use is limited to use by approved users.
DUO:0000027 version: 2019-01-07
project specific restriction
This data use modifier indicates that use is limited to use within an approved project.
DUO:0000028 version: 2019-01-07
institution specific restriction
This data use modifier indicates that use is limited to use within an approved institution.
The data can only be used for cancer research that is inline with the research areas delineated in the patient consent. These include cancer biomarkers, prognostic factors, mechanisms behind the tumor evolution during treatment and treatment options. The data can also be used for validation of studies published by the contributing consortia (MUPETFaasi2, HERCULES, CHEMORESPONSE).
The data can only be used for cancer research that is inline with the research areas delineated in the patient consent. These include cancer biomarkers, prognostic factors, mechanisms behind the tumor evolution during treatment and treatment options. The data can also be used for validation of studies published by the contributing consortia (MUPETFaasi2, HERCULES, CHEMORESPONSE). See link for full description
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001006775 | Other |